← Leaderboards
Dario Campana
St. Jude Children'S Research Hospital
$6,388,379
Attributed
$6,388,379
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $800.3K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$6,388,379 · 5
By mechanism
R01$6,388,379 · 5
Top collaborators
No co-investigators on record.
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Richard James Gilbertson$38,555,720
- Michael A Dyer$24,988,379
- Charles G. Mullighan$25,123,215
- Charles W Roberts$21,463,141
- Brian P Sorrentino$13,809,294
Others in their field
Top investigators on “Bone Marrow”
- Charles A Coltman · Southwest Oncology Group$141,983,231
- Mary M Horowitz · Medical College Of Wisconsin$136,789,389
- David Heimbrook · Leidos Biomedical Research, Inc.$56,049,457
- Richard L Schilsky · University Of Chicago$50,043,295
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$48,148,202
- J. Mark Cline · Wake Forest University$31,844,583
Research focus
Bone MarrowClinical ResearchAcute Lymphocytic LeukemiaGene ExpressionHuman SubjectFlow CytometryLeukemic CellIn VivoLeukemia, Lymphocytic, AcuteNormal CellDiagnosis Design /EvaluationLeukemiaStem CellsNeoplasm /Cancer DiagnosisChildHematopoietic Stem CellsRelapseCellsGenesMicroarray TechnologyMinimal Residual DiseaseCell Adhesion MoleculesPediatric Neoplasm /CancerNeoplasm /Cancer Relapse /Recurrence
Grant awards (25)
Cell Therapy of Refractory Leukemia$289,553
R01 · FY2010 · CA · contact PI
Clinical Significance of Residual Myeloid Leukemia$260,597
R01 · FY2010 · CA · contact PI
Cell Therapy of Refractory Leukemia$289,553
R01 · FY2009 · CA · contact PI
Clinical Significance of Residual Myeloid Leukemia$260,597
R01 · FY2009 · CA · contact PI
Cell Therapy of Refractory Leukemia$286,536
R01 · FY2008 · CA · contact PI
Clinical Significance of Residual Myeloid Leukemia$260,208
R01 · FY2008 · CA · contact PI
Cell Therapy of Refractory Leukemia$281,365
R01 · FY2007 · CA · contact PI
Clinical Significance of Residual Myeloid Leukemia$255,555
R01 · FY2007 · CA · contact PI
Cell Therapy of Refractory Leukemia$285,479
R01 · FY2006 · CA · contact PI
Clinical Significance of Residual Myeloid Leukemia$258,529
R01 · FY2006 · CA · contact PI
Detection and Therapy of Residual Leukemia in Children$256,332
R01 · FY2006 · CA · contact PI
Detection and Therapy of Residual Leukemia in Children$262,500
R01 · FY2005 · CA
Immunoglobulin Gene Arrangement/Expression in Leukemia$213,750
R01 · FY2005 · CA
Beta CELL PROGENITORS AND BONE MARROW MICROENVIRONMENT$324,000
R01 · FY2004 · CA
Detection and Therapy of Residual Leukemia in Children$262,500
R01 · FY2004 · CA
Immunoglobulin Gene Arrangement/Expression in Leukemia$213,750
R01 · FY2004 · CA
Detection and Therapy of Residual Leukemia in Children$262,500
R01 · FY2003 · CA
Beta CELL PROGENITORS AND BONE MARROW MICROENVIRONMENT$249,000
R01 · FY2003 · CA
Immunoglobulin Gene Arrangement/Expression in Leukemia$213,750
R01 · FY2003 · CA
Detection and Therapy of Residual Leukemia in Children$262,500
R01 · FY2002 · CA
Beta CELL PROGENITORS AND BONE MARROW MICROENVIRONMENT$249,000
R01 · FY2002 · CA
Beta CELL PROGENITORS AND BONE MARROW MICROENVIRONMENT$247,340
R01 · FY2001 · CA
DETECTION AND THERAPY OF RESIDUAL LEUKEMIA IN CHILDREN$209,961
R01 · FY2001 · CA
B CELL PROGENITORS AND BONE MARROW MICROENVIRONMENT$229,567
R01 · FY2000 · CA
DETECTION AND THERAPY OF RESIDUAL LEUKEMIA IN CHILDREN$203,957
R01 · FY2000 · CA